Protagonist Therapeutics Aktie
81,49
USD
-0,44
USD
-0,54
%
81,50
USD
-0,38
USD
-0,46
%
Werbung
Protagonist Therapeutics Aktie Analyse
| 08.07.19 | Protagonist Therapeutics Buy | H.C. Wainwright & Co. | |
| 22.02.19 | Protagonist Therapeutics Outperform | BMO Capital Markets | |
| 29.01.18 | Protagonist Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
| 21.07.17 | Protagonist Therapeutics Buy | BTIG Research | |
| 06.09.16 | Protagonist Therapeutics overweight | Barclays Capital |
Werbung
Werbung